Torray Investment Partners’s Elevance Health ELV Stock Holding History

Torray Investment Partners’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-41,300	Closed	-$7.84M	–	109
2017 Q3	$7.84M	Hold	41,300	–	–	0.78%	60
2017 Q2	$7.77M	Hold	41,300	–	–	0.82%	58
2017 Q1	$6.83M	Hold	41,300	–	–	0.72%	57
2016 Q4	$5.94M	Hold	41,300	–	–	0.63%	58
2016 Q3	$5.17M	Hold	41,300	–	–	0.57%	58
2016 Q2	$5.42M	Sell	41,300 -1,036	-2%	-$142K	0.41%	60
2016 Q1	$5.88M	Buy	42,336 +20	+0%	+$2.67K	0.31%	61
2015 Q4	$5.9M	Buy	42,316 +80	+0.2%	+$11K	0.44%	58
2015 Q3	$5.91M	Hold	42,236	–	–	0.43%	59
2015 Q2	$6.93M	Buy	42,236 +40,905	+3,073%	+$6.54M	0.45%	59
2015 Q1	$206K	Sell	1,331 -74,543	-98%	-$10.6M	0.02%	65
2014 Q4	$9.54M	Sell	75,874 -24,626	-25%	-$3.04M	0.8%	56
2014 Q3	$12M	Hold	100,500	–	–	1.09%	44
2014 Q2	$10.8M	Hold	100,500	–	–	1.1%	52
2014 Q1	$10M	Sell	100,500 -25,000	-20%	-$2.26M	1.7%	30
2013 Q4	$11.6M	Hold	125,500	–	–	2.41%	18
2013 Q3	$10.5M	Hold	125,500	–	–	2.26%	23
2013 Q2	$10.3M	Buy	+125,500	New	+$9.39M	2.24%	22

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Torray Investment Partners's ELV Position: Q4 2017 in Review

Torray Investment Partners sold out of Elevance Health (ELV) in Q4 2017, closing a stake of 41,300 shares — an estimated $7.84M sold.

Torray Investment Partners first reported a position in ELV in Q2 2013 and held it in 18 quarters. The position peaked at $12M in Q3 2014. 909 funds tracked by Wall St. Rank hold ELV as of Q4 2017.

Torray Investment Partners reported no remaining Elevance Health position as of Q4 2017 after selling out during the quarter.
Torray Investment Partners sold 41,300 Elevance Health shares in Q4 2017, an estimated $7.84M.
Torray Investment Partners first reported a position in Elevance Health in Q2 2013 and held it in 18 quarters.
Torray Investment Partners's Elevance Health position peaked at $12M in Q3 2014.
909 funds tracked by Wall St. Rank held Elevance Health as of Q4 2017.

Based on Torray Investment Partners's 13F filing for Q4 2017, filed 13 Feb 2018.